1[1]The SHEP Cooperative Research Group,JAHA,1991,265:3255 被引量：1
2[2]Some GW et al.The role of diastolic blood pressure when treating isolated systolic hyoertension.Arch Int Med,1999,159:2004 被引量：1
3[3]Tuomilehto J.Rasbeenyte D.Birkenhager WH.Effects of calcium channel block tade in older penitents with diabetes and systolie hypertension.NENGL J Med,1999,340:677 被引量：1
4[4]Wang J -G SJA et al.Chinese trial on isolated systohe hypertension in the elderly.Arch Int Med,2000,160:211 被引量：1
5[5]Hansson L et al,Effect of ACE-Ⅰ compared with conventional therapy on cardiovascular morbidity and mortality in hypertension:The Captopril Prevention Project(CAPPP) randomized trial.Lancet,1999,353:611 被引量：1
6[6]Yusuf S.Sleight P et al.Effect of an ACE-Ⅰ ramipril,on cardiovascular events in high -risk pt.The HOPE.Investigators ENJM,2000,342:145 被引量：1
8[8]Hansson L et al.Randonized trial of old and new antihypertensive in elderly patients:Cardiorascular mortality and morbidity in the STOP-Hypertension 2 study.Lancet,1999,354:1751 被引量：1
9[9]Liu L,Wang J,Gong L,er al,Compsrison of active treatment and placebo in older Chinese pts with isolated systolic hypertensiln.Syst-China Collaborative J Hypertens,1998,16:2113 被引量：1
10[10]Mancia Group INSIGHT 试验.Am J CARDIOL 82:23R.1998 被引量：1
二级参考文献8
1Dahl of B, Lindholm LH, Hansson L,et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension(STOP-Hypertension). Lancet, 1991, 338(8778): 1281～1285 被引量：1
2Hansson L, Lindholm LH, Ekbom T, et al. Randomised trial of old and newantihypertensive drugs in elderly patients: cardiovascular mortality and morbidity theSwedish Trial in Old Patients with Hypertension-2 study. Lancet, 1999, 354(9192): 1751～1756 被引量：1
3Guidelines Subcommittee. 1999 World Health Organization-International Society ofHypertension guidelines for the management of hypertension. J Hypertens, 1999, 17(2): 151～183 被引量：1
4The sixth report of the Joint National Committee on Prevention, Detection,Evaluation, and Treatment of High Blood Pressure. Arch Intern Med, 1997, 157(21): 2413～2446 被引量：1
5Hansson L, lindholm LH, Niskanen L, et al. Effect of angiotensin - converting -enzyme inhibition compared with conventional therapy on cardiovascular morbidity andmortality in hypertension: the Csptepril Prevention Project (CAPPP) randomised trial.Lancet, 1993, 353(9153): 611～616 被引量：1
6Staessen JA, Thijs L, Fagard RH, et al. Calcium channel blockade and cardiovascularprognosis in the European trial on isolated systolic hypertension. Hyperension, 1998,32(3): 410～416 被引量：1
7UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducingrisk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ,1998, 317(7160): 713～720 被引量：1
8Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood - pressurelowering and low - dose aspirin in patients with bypertension: principal results of theHypertension Optimal Treatment (HOT) randomised trial. Lancet, 1998, 351(9118): 1755～1762 被引量：1
